Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 237 articles:
HTML format
Text format



Single Articles


    December 2019
  1. YANG Y, Liu C, Qi L, Zhao T, et al
    Diagnosis of Pre-HCC Disease by Hepatobiliary-Specific Contrast-Enhanced Magnetic Resonance Imaging: A Review.
    Dig Dis Sci. 2019 Dec 5. pii: 10.1007/s10620-019-05981.
    PubMed     Text format     Abstract available


    November 2019
  2. CANNON MD, Martin P, Carrion AF
    Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.
    Dig Dis Sci. 2019 Nov 25. pii: 10.1007/s10620-019-05943.
    PubMed     Text format     Abstract available


  3. OU HY, Cheng YF, Chuang YH, Hsu HW, et al
    Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Nov 15. pii: 10.1007/s10620-019-05951.
    PubMed     Text format     Abstract available


  4. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    PubMed     Text format     Abstract available


  5. GU C, Chai M, Liu J, Wang H, et al
    Expansion of Transdifferentiated Human Hepatocytes in a Serum-Free Microcarrier Culture System.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05925.
    PubMed     Text format     Abstract available


  6. GOUDRA B, Singh PM
    GI Endoscopy Sedation in Patients with Cirrhosis: Routine or Unpredictable?
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05949.
    PubMed     Text format    


  7. VUYYURU SK, Singh AD, Gamanagatti SR, Rout G, et al
    A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05939.
    PubMed     Text format     Abstract available


  8. ZONG G, Xu Z, Zhang S, Shen Y, et al
    Retraction Note: CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2019 Nov 11. pii: 10.1007/s10620-019-05932.
    PubMed     Text format     Abstract available


  9. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    PubMed     Text format     Abstract available


    October 2019
  10. BIAN X, He X, Yang L, Wu W, et al
    Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05917.
    PubMed     Text format     Abstract available


  11. LING C, Khalid S, Martin D, Hanson J, et al
    HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05920.
    PubMed     Text format    


  12. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Dig Dis Sci. 2019 Oct 28. pii: 10.1007/s10620-019-05813.
    PubMed     Text format     Abstract available


  13. SCAGLIONE S, Adams W, Caines A, Devlin P, et al
    Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05890.
    PubMed     Text format     Abstract available


  14. STINE JG, Intagliata NM, Shah NL, Lisman T, et al
    Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.
    Dig Dis Sci. 2019 Oct 18. pii: 10.1007/s10620-019-05884.
    PubMed     Text format     Abstract available


  15. WANG JH, Ou HY, Yen YH, Chen CH, et al
    Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
    Dig Dis Sci. 2019 Oct 15. pii: 10.1007/s10620-019-05883.
    PubMed     Text format     Abstract available


  16. EDELSON J, Suarez AL, Zhang J, Rockey DC, et al
    Sedation During Endoscopy in Patients with Cirrhosis: Safety and Predictors of Adverse Events.
    Dig Dis Sci. 2019 Oct 12. pii: 10.1007/s10620-019-05845.
    PubMed     Text format     Abstract available


  17. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    PubMed     Text format     Abstract available


  18. WEN X, Ling S, Wu W, Shan Q, et al
    Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Oct 5. pii: 10.1007/s10620-019-05844.
    PubMed     Text format     Abstract available


    September 2019
  19. THOMSON MJ, Taylor A, Sharma P, Lok AS, et al
    Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2019 Sep 30. pii: 10.1007/s10620-019-05858.
    PubMed     Text format     Abstract available


  20. LI Y, Li Z, Jia Y, Ding B, et al
    In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21.
    Dig Dis Sci. 2019 Sep 26. pii: 10.1007/s10620-019-05856.
    PubMed     Text format     Abstract available


  21. KOOLA JD, Ho SB, Cao A, Chen G, et al
    Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2019 Sep 17. pii: 10.1007/s10620-019-05826.
    PubMed     Text format     Abstract available


  22. GU S, Chen J, Zhou Q, Yan M, et al
    LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05806.
    PubMed     Text format     Abstract available


    August 2019
  23. ZHOU Y, Zhang Q, Kong Y, Guo X, et al
    Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05798.
    PubMed     Text format     Abstract available


  24. SHERMAN KE, Abdel-Hameed EA, Ehman RL, Rouster SD, et al
    Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05815.
    PubMed     Text format     Abstract available


  25. WALLACE MC, Sek K, Francis RJ, Samuelson S, et al
    Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05781.
    PubMed     Text format     Abstract available


  26. FEUERSTADT P, Hong SJ, Brandt LJ
    Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05804.
    PubMed     Text format     Abstract available


  27. DONG Z, Liao B, Shen W, Sui C, et al
    Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2019 Aug 13. pii: 10.1007/s10620-019-05787.
    PubMed     Text format     Abstract available


    July 2019
  28. COSTENTIN CE, Sogni P, Falissard B, Barbare JC, et al
    Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
    Dig Dis Sci. 2019 Jul 25. pii: 10.1007/s10620-019-05724.
    PubMed     Text format     Abstract available


  29. TAO J, Li J, Chen X, Guo Y, et al
    Endoscopic Variceal Sequential Ligation Does Not Increase Risk of Gastroesophageal Reflux Disease in Cirrhosis Patients.
    Dig Dis Sci. 2019 Jul 22. pii: 10.1007/s10620-019-05740.
    PubMed     Text format     Abstract available


  30. SONG Q, Ren W, Fan L, Zhao M, et al
    Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Dig Dis Sci. 2019 Jul 17. pii: 10.1007/s10620-019-05733.
    PubMed     Text format     Abstract available


  31. SAMJI NS, Verma R, Keri KC, Singal AK, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05716.
    PubMed     Text format     Abstract available


  32. TUCKER RD, Ciofoaia V, Nadella S, Gay MD, et al
    A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Jul 11. pii: 10.1007/s10620-019-05722.
    PubMed     Text format     Abstract available


  33. TAPPER EB, Derstine B, Baki J, Su GL, et al
    Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jul 10. pii: 10.1007/s10620-019-05713.
    PubMed     Text format     Abstract available


    June 2019
  34. SEMMLER G, Stift J, Scheiner B, Woran K, et al
    Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
    Dig Dis Sci. 2019 Jun 17. pii: 10.1007/s10620-019-05702.
    PubMed     Text format     Abstract available


  35. SOMMARIVA C, Lauro A, Pagano N, Vaccari S, et al
    Subcapsular Hepatic Hematoma Post-ERCP: Case Report and Review of the Literature.
    Dig Dis Sci. 2019 Jun 13. pii: 10.1007/s10620-019-05679.
    PubMed     Text format     Abstract available


  36. KIM DS, Lim TS, Jeon MY, Kim BK, et al
    Transarterial Chemoembolization in Treatment-Naive and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05701.
    PubMed     Text format     Abstract available


  37. MANKA P, Bechmann L, Best J, Sydor S, et al
    Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2019 Jun 3. pii: 10.1007/s10620-019-05687.
    PubMed     Text format     Abstract available


  38. CROPLEY A, Ashrafy AH, Weltman M
    An Original Description of Granulomatous Liver Cirrhosis in Blau Syndrome.
    Dig Dis Sci. 2019 Jun 1. pii: 10.1007/s10620-019-05682.
    PubMed     Text format    


  39. JENSEN CW, Worhunsky DJ, Triadafilopoulos G, Bingham DB, et al
    Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas.
    Dig Dis Sci. 2019;64:1436-1438.
    PubMed     Text format    


  40. LIU J, Li H, Sun L, Shen S, et al
    Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
    Dig Dis Sci. 2019;64:1523-1534.
    PubMed     Text format     Abstract available


    May 2019
  41. CORBI LE, Tannuri ACA, de Aro Braz MJ, Paes VR, et al
    Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?
    Dig Dis Sci. 2019 May 10. pii: 10.1007/s10620-019-05658.
    PubMed     Text format     Abstract available


  42. SIRAMOLPIWAT S, Punjachaipornpon T, Pornthisarn B, Vilaichone RK, et al
    N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial Chemoembolization.
    Dig Dis Sci. 2019 May 9. pii: 10.1007/s10620-019-05652.
    PubMed     Text format     Abstract available


  43. ALMANZA D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, et al
    Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.
    Dig Dis Sci. 2019;64:1257-1269.
    PubMed     Text format     Abstract available


    April 2019
  44. LI X, Jiang F, Ge Z, Chen B, et al
    Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05642.
    PubMed     Text format     Abstract available


  45. ZOU WY, Choi K, Kramer JR, Yu X, et al
    Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
    PubMed     Text format     Abstract available


  46. DEMORROW S
    Concise Commentary: Staying True to Type-The Increasing Inpatient Burden of Hepatic Encephalopathy.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05630.
    PubMed     Text format    


  47. KARAGIANNAKIS DS, Voulgaris T, Koureta E, Chloupi E, et al
    Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05616.
    PubMed     Text format     Abstract available


  48. NAKATAKE R, Hishikawa H, Kotsuka M, Ishizaki M, et al
    The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05622.
    PubMed     Text format     Abstract available


  49. YU B, Ding Y, Liao X, Wang C, et al
    Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Apr 4. pii: 10.1007/s10620-019-05608.
    PubMed     Text format     Abstract available


  50. PILLAI A, Couri T, Charlton M
    Liver Allocation Policies in the USA: Past, Present, and the Future.
    Dig Dis Sci. 2019;64:985-992.
    PubMed     Text format     Abstract available


  51. GADSDEN MM, Kaplan DE
    Multidisciplinary Approach to HCC Management: How Can This Be Done?
    Dig Dis Sci. 2019;64:968-975.
    PubMed     Text format     Abstract available


  52. LANGE N, Dufour JF
    Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
    Dig Dis Sci. 2019;64:903-909.
    PubMed     Text format     Abstract available


  53. BAILEY CW, Sydnor MK Jr
    Current State of Tumor Ablation Therapies.
    Dig Dis Sci. 2019;64:951-958.
    PubMed     Text format     Abstract available


  54. VOGL TJ, Gruber-Rouh T
    HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.
    Dig Dis Sci. 2019;64:959-967.
    PubMed     Text format     Abstract available


  55. SHERMAN M
    Design and Endpoints of Clinical Trials, Current and Future.
    Dig Dis Sci. 2019;64:1050-1057.
    PubMed     Text format     Abstract available


  56. FLOUDAS CS, Brar G, Greten TF
    Immunotherapy: Current Status and Future Perspectives.
    Dig Dis Sci. 2019;64:1030-1040.
    PubMed     Text format     Abstract available


  57. LONGERICH T, Schirmacher P
    Emerging Role of the Pathologist in Precision Medicine for HCC.
    Dig Dis Sci. 2019;64:928-933.
    PubMed     Text format    


    March 2019
  58. KOHLI R, Shingina A, New S, Chaturvedi S, et al
    Thromboelastography Parameters Are Associated with Cirrhosis Severity.
    Dig Dis Sci. 2019 Mar 26. pii: 10.1007/s10620-019-05597.
    PubMed     Text format     Abstract available


  59. YOON YI, Lee SG
    Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective.
    Dig Dis Sci. 2019 Mar 20. pii: 10.1007/s10620-019-05551.
    PubMed     Text format     Abstract available


  60. SAFFO S, Taddei TH
    Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies.
    Dig Dis Sci. 2019 Mar 18. pii: 10.1007/s10620-019-05582.
    PubMed     Text format     Abstract available


  61. LUO X, Liu Y, Ma S, Liu L, et al
    WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 15. pii: 10.1007/s10620-019-05583.
    PubMed     Text format     Abstract available


  62. SONI PD, Palta M
    Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
    Dig Dis Sci. 2019 Mar 14. pii: 10.1007/s10620-019-05539.
    PubMed     Text format     Abstract available


  63. WEI M, Ford J, Li Q, Jeong D, et al
    Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05558.
    PubMed     Text format     Abstract available


  64. HIRODE G, Vittinghoff E, Wong RJ
    Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05576.
    PubMed     Text format     Abstract available


  65. FUCHS M, Levy MF
    Introduction to the Emmet B. Keeffe, MD, Commemorative Special Issue on Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 12. pii: 10.1007/s10620-019-05574.
    PubMed     Text format    


  66. SPOSITO C, Cucchetti A, Mazzaferro V
    Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05538.
    PubMed     Text format     Abstract available


  67. NORONHA FERREIRA C, Reis D, Cortez-Pinto H, Tato Marinho R, et al
    Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05572.
    PubMed     Text format     Abstract available


  68. KHAN RS, Newsome PN
    Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus?
    Dig Dis Sci. 2019 Mar 7. pii: 10.1007/s10620-019-05573.
    PubMed     Text format    


  69. REICHMAN TW, Bhati CS, Battula NR
    Obtaining Optimal Long-Term Outcomes from Liver Transplantation for Hepatocellular Cancer.
    Dig Dis Sci. 2019 Mar 6. pii: 10.1007/s10620-019-05550.
    PubMed     Text format     Abstract available


  70. HARDING JJ, Khalil DN, Abou-Alfa GK
    Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05517.
    PubMed     Text format     Abstract available


  71. SAYINER M, Golabi P, Younossi ZM
    Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05537.
    PubMed     Text format     Abstract available


  72. ROUT G, Sharma S, Gunjan D, Kedia S, et al
    Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.
    Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05557.
    PubMed     Text format     Abstract available


  73. MA L, Ishigami M, Honda T, Yokoyama S, et al
    Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05560.
    PubMed     Text format     Abstract available


  74. RONOT M, Purcell Y, Vilgrain V
    Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05547.
    PubMed     Text format     Abstract available


  75. DISMUKE-GREER CE, Syn WK
    Coming Complications of Nonalcoholic Fatty Liver Disease: Time to GNASH Your Teeth.
    Dig Dis Sci. 2019;64:606-608.
    PubMed     Text format    


  76. ZHANG W, Chao S, Chen S, Rao H, et al
    Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China.
    Dig Dis Sci. 2019;64:708-717.
    PubMed     Text format     Abstract available


  77. MANTOVANI A
    Nonalcoholic Fatty Liver Disease and Bone Mineral Density in Children and Adolescents: Specific Considerations for Future Studies.
    Dig Dis Sci. 2019;64:898-900.
    PubMed     Text format    


  78. KANG HT, Jun DW, Jang K, Hoh JK, et al
    Effect of Stem Cell Treatment on Acute Liver Failure Model Using Scaffold.
    Dig Dis Sci. 2019;64:781-791.
    PubMed     Text format     Abstract available


  79. NGUYEN AL, Park H, Nguyen P, Sheen E, et al
    Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.
    Dig Dis Sci. 2019;64:698-707.
    PubMed     Text format     Abstract available


    February 2019
  80. JIAN ZW, Wu XW, Chen ZX, Wang JC, et al
    Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05543.
    PubMed     Text format     Abstract available


  81. XIAO Y, Zhang S, Li Q, Liu Z, et al
    miR-219a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury via Impairing TP53BP2.
    Dig Dis Sci. 2019 Feb 22. pii: 10.1007/s10620-019-05535.
    PubMed     Text format     Abstract available


  82. ARDOLINO E, Wang SS, Patwardhan VR
    Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2019 Feb 14. pii: 10.1007/s10620-019-05519.
    PubMed     Text format     Abstract available


  83. ZHAO J, Xu H, Li Y, Gong L, et al
    NAFLD Induction Delays Postoperative Liver Regeneration of ALPPS in Rats.
    Dig Dis Sci. 2019;64:456-468.
    PubMed     Text format     Abstract available


  84. XI L, Zhu J, Zhang H, Muktiali M, et al
    Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study.
    Dig Dis Sci. 2019;64:532-543.
    PubMed     Text format     Abstract available


    January 2019
  85. NEVENS F, Bittencourt PL, Coenraad MJ, Ding H, et al
    Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-018-5448.
    PubMed     Text format     Abstract available


  86. LAI LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, et al
    Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.
    Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-019-5477.
    PubMed     Text format     Abstract available


  87. BARRITT AS 4TH, Jiang Y, Schmidt M, Hayashi PH, et al
    Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5471.
    PubMed     Text format     Abstract available


  88. TANSEL A, Kramer J, Feng H, El-Serag HB, et al
    Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5459.
    PubMed     Text format     Abstract available


  89. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5462.
    PubMed     Text format     Abstract available


  90. THEOCHARIDOU E, Giouleme O, Anastasiadis S, Markopoulou A, et al
    Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis.
    Dig Dis Sci. 2019 Jan 19. pii: 10.1007/s10620-019-5460.
    PubMed     Text format     Abstract available


  91. BERNARDI N, Chedid MF, Grezzana-Filho TJM, Chedid AD, et al
    Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation.
    Dig Dis Sci. 2019 Jan 14. pii: 10.1007/s10620-019-5456.
    PubMed     Text format     Abstract available


  92. WANG S, Liang C, Ai H, Yang M, et al
    Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1.
    Dig Dis Sci. 2019 Jan 9. pii: 10.1007/s10620-018-5442.
    PubMed     Text format     Abstract available


  93. DAKHOUL L, Jones KR, Gawrieh S, Ghabril M, et al
    Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2019 Jan 7. pii: 10.1007/s10620-018-5441.
    PubMed     Text format     Abstract available


  94. LEE KC, Hsu WF, Hsieh YC, Chan CC, et al
    Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
    Dig Dis Sci. 2019;64:102-112.
    PubMed     Text format     Abstract available


  95. JIAO Y, Li Y, Lu Z, Liu Y, et al
    High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
    Dig Dis Sci. 2019;64:137-143.
    PubMed     Text format     Abstract available


  96. JIN X, Zimmers TA, Zhang Z, Koniaris LG, et al
    Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.
    Dig Dis Sci. 2019;64:93-101.
    PubMed     Text format     Abstract available


  97. ROSENBLATT R, Mehta A, Snell D, Hissong E, et al
    Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Dig Dis Sci. 2019;64:262-268.
    PubMed     Text format     Abstract available


  98. LI P, Shan K, Liu Y, Zhang Y, et al
    CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway.
    Dig Dis Sci. 2019;64:113-122.
    PubMed     Text format     Abstract available


    December 2018
  99. STINE JG, Northup PG
    Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5427.
    PubMed     Text format     Abstract available


  100. KAKAR S, Dugum M, Cabello R, Humar A, et al
    Incidence of Recurrent NASH-Related Allograft Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5413.
    PubMed     Text format     Abstract available


  101. MAIMONE S, Saffioti F, Filomia R, Alibrandi A, et al
    Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5412.
    PubMed     Text format     Abstract available


  102. HUANG X, Gao Y, Qin J, Lu S, et al
    miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5405.
    PubMed     Text format     Abstract available


  103. PINERO F, Rubinstein F, Marciano S, Fernandez N, et al
    Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5390.
    PubMed     Text format     Abstract available


  104. TOLBOL KS, Stierstorfer B, Rippmann JF, Veidal SS, et al
    Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5395.
    PubMed     Text format     Abstract available


  105. SHETTY A, Hsu JW, Manka PP, Syn WK, et al
    Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018;63:3187-3206.
    PubMed     Text format     Abstract available


    November 2018
  106. MATSUURA Y, Wada H, Eguchi H, Gotoh K, et al
    Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
    Dig Dis Sci. 2018 Nov 22. pii: 10.1007/s10620-018-5380.
    PubMed     Text format     Abstract available


  107. WANG B, Zhao KL, Hu WJ, Zuo T, et al
    Macrophage Migration Inhibitor Promoted the Intrahepatic Bile Duct Injury in Rats with Severe Acute Pancreatitis.
    Dig Dis Sci. 2018 Nov 22. pii: 10.1007/s10620-018-5379.
    PubMed     Text format     Abstract available


  108. JARA M, Dziodzio T, Malinowski M, Luttgert K, et al
    Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2018 Nov 7. pii: 10.1007/s10620-018-5360.
    PubMed     Text format     Abstract available


  109. DE MARIA C, Ghidotti I, Grillo F, Giannini EG, et al
    Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Nov 1. pii: 10.1007/s10620-018-5356.
    PubMed     Text format    


    October 2018
  110. MURPHY SL, Tapper EB, Blackwood J, Richardson JK, et al
    Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5333.
    PubMed     Text format     Abstract available


  111. LIEW ZH, Goh GB, Hao Y, Chang PE, et al
    Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5331.
    PubMed     Text format     Abstract available


  112. CHO SY, Kim S, Son MJ, Rou WS, et al
    Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Oct 4. pii: 10.1007/s10620-018-5307.
    PubMed     Text format     Abstract available


    September 2018
  113. KORNBERG A, Schernhammer M, Kornberg J, Friess H, et al
    Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5296.
    PubMed     Text format     Abstract available


  114. YANNY B, Saab S, Durazo F, Latt N, et al
    Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
    PubMed     Text format     Abstract available


  115. OU Q, Weng Y, Wang S, Zhao Y, et al
    Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-kappaB Pathway.
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5268.
    PubMed     Text format     Abstract available


  116. CHASCSA DM, Lai JC, Dunn MA, Montano-Loza AJ, et al
    Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5271.
    PubMed     Text format     Abstract available


  117. CAO LL, Pei XF, Qiao X, Yu J, et al
    SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
    Dig Dis Sci. 2018;63:2309-2319.
    PubMed     Text format     Abstract available


  118. PATEL YA, Gifford EJ, Glass LM, Turner MJ, et al
    Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Dig Dis Sci. 2018;63:2259-2266.
    PubMed     Text format     Abstract available


    August 2018
  119. KIM HJ, Kang TU, Swan H, Kang MJ, et al
    Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones.
    Dig Dis Sci. 2018 Aug 31. pii: 10.1007/s10620-018-5262.
    PubMed     Text format     Abstract available


  120. ADDEPALLY NS, George N, Martinez-Macias R, Garcia-Saenz-de-Sicilia M, et al
    Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Aug 29. pii: 10.1007/s10620-018-5265.
    PubMed     Text format     Abstract available


  121. ZHANG G, Yu X, Liu P, Huang X, et al
    Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
    Dig Dis Sci. 2018 Aug 23. pii: 10.1007/s10620-018-5252.
    PubMed     Text format     Abstract available


    July 2018
  122. KALIANNAN K
    Compromise of alpha-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia.
    Dig Dis Sci. 2018 Jul 14. pii: 10.1007/s10620-018-5197.
    PubMed     Text format    


  123. SORENSEN M, Larsen LP, Villadsen GE, Aagaard NK, et al
    beta-Blockers Improve Presinusoidal Portal Hypertension.
    Dig Dis Sci. 2018 Jul 12. pii: 10.1007/s10620-018-5186.
    PubMed     Text format     Abstract available


  124. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    PubMed     Text format    


  125. MANTOVANI A, Grani G
    Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.
    Dig Dis Sci. 2018;63:1970-1976.
    PubMed     Text format    


    June 2018
  126. ZHANG S, Gong Y, Xiao J, Chai Y, et al
    A COL1A1 Promoter-Controlled Expression of TGF-beta Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
    Dig Dis Sci. 2018 Jun 23. pii: 10.1007/s10620-018-5168.
    PubMed     Text format     Abstract available


  127. LENHART A, Hussain S, Salgia R
    Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis.
    Dig Dis Sci. 2018 Jun 22. pii: 10.1007/s10620-018-5170.
    PubMed     Text format     Abstract available


  128. OU H, Huang Y, Xiang L, Chen Z, et al
    Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Jun 21. pii: 10.1007/s10620-018-5124.
    PubMed     Text format     Abstract available


  129. TSIAOUSSIS GI, Papaioannou EC, Kourea EP, Assimakopoulos SF, et al
    Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.
    Dig Dis Sci. 2018 Jun 7. pii: 10.1007/s10620-018-5146.
    PubMed     Text format     Abstract available


  130. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    PubMed     Text format     Abstract available


    May 2018
  131. BAJAJ JS, Ross D
    Concise Commentary: Remaining Outside the Hospital Is a Golden State in Cirrhosis-Lessons from California.
    Dig Dis Sci. 2018 May 30. pii: 10.1007/s10620-018-5134.
    PubMed     Text format    


  132. WALLACE MC, Knuiman M, Huang Y, Garas G, et al
    The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.
    Dig Dis Sci. 2018 May 28. pii: 10.1007/s10620-018-5132.
    PubMed     Text format     Abstract available


  133. JOPSON L, Khanna A, Peterson P, Rudell E, et al
    Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5074.
    PubMed     Text format     Abstract available


  134. SHEN J, Liu J, Li C, Wen T, et al
    The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2018 May 7. pii: 10.1007/s10620-018-5077.
    PubMed     Text format     Abstract available


  135. WANG P, Li Z, Ren S, Li J, et al
    Spleen Regulates Hematopoietic Stem/Progenitor Cell Functions Through Regulation of EGF in Cirrhotic Hypersplenism.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5091.
    PubMed     Text format     Abstract available


  136. FACCIORUSSO A, Roy S, Livadas S, Fevrier-Paul A, et al
    Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5092.
    PubMed     Text format     Abstract available


  137. ROTH CG, Marzio DH, Guglielmo FF
    Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.
    Dig Dis Sci. 2018;63:1102-1122.
    PubMed     Text format     Abstract available


  138. KAUNITZ JD
    Magnetic Resonance Imaging: The Nuclear Option.
    Dig Dis Sci. 2018;63:1100-1101.
    PubMed     Text format    


  139. NIU B, Kim B, Limketkai BN, Sun J, et al
    Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA.
    Dig Dis Sci. 2018;63:1327-1333.
    PubMed     Text format     Abstract available


    April 2018
  140. GARCIA-RODRIGUEZ MT, Pertega-Diaz S, Lopez-Calvino B, Pinon-Villar MDC, et al
    Nomogram and Validity of a Model for Predicting Malnutrition in Patients on Liver Transplant Lists.
    Dig Dis Sci. 2018 Apr 25. pii: 10.1007/s10620-018-5079.
    PubMed     Text format     Abstract available


  141. ILAN Y
    Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?
    Dig Dis Sci. 2018 Apr 20. pii: 10.1007/s10620-018-5080.
    PubMed     Text format     Abstract available


  142. SAFADI S, Delu AN, Alcorn J, McCarthy D, et al
    Portal Hypertensive Bleeding: A Navel Approach.
    Dig Dis Sci. 2018 Apr 19. pii: 10.1007/s10620-018-5062.
    PubMed     Text format    


  143. GIANNINI EG, Coppo C, Romana C, Camerini GB, et al
    Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
    Dig Dis Sci. 2018 Apr 9. pii: 10.1007/s10620-018-5052.
    PubMed     Text format     Abstract available


  144. GADIPARTHI C, Cholankeril G, Yoo ER, Hu M, et al
    Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Dig Dis Sci. 2018 Apr 2. pii: 10.1007/s10620-018-5032.
    PubMed     Text format     Abstract available


    March 2018
  145. PONZETTO A, Vaira D
    Hepatic Encephalopathy and Helicobacter pylori.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5038.
    PubMed     Text format    


  146. DANIELSEN KV, Wiese S, Hove J, Bendtsen F, et al
    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-5006.
    PubMed     Text format     Abstract available


  147. ZOU WY, El-Serag HB, Sada YH, Temple SL, et al
    Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Dig Dis Sci. 2018 Mar 5. pii: 10.1007/s10620-018-4989.
    PubMed     Text format     Abstract available


  148. GREMIDA A, Paleti S, Perez ET, McCarthy D, et al
    Hemolysis in Alcoholic Liver Disease: Zieve's Syndrome.
    Dig Dis Sci. 2018;63:601-604.
    PubMed     Text format    


    February 2018
  149. VARDI I, Barel O, Sperber M, Schvimer M, et al
    Genetic and Structural Analysis of a SKIV2L Mutation Causing Tricho-hepato-enteric Syndrome.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4983.
    PubMed     Text format     Abstract available


  150. KOUNTOURAS J, Polyzos SA, Katsinelos P, Anastasiadis S, et al
    Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4911.
    PubMed     Text format    


  151. WEI M, Ford J, Li Q, Jeong D, et al
    Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-018-4964.
    PubMed     Text format     Abstract available


  152. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    PubMed     Text format     Abstract available


  153. KIM JH, Sinn DH, Lee JH, Hyun D, et al
    Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4934.
    PubMed     Text format     Abstract available


  154. YU Z, Wang R, Chen F, Wang J, et al
    Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4961.
    PubMed     Text format     Abstract available


  155. MINDIKOGLU AL, Opekun AR, Mitch WE, Magder LS, et al
    Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Feb 1. pii: 10.1007/s10620-017-4897.
    PubMed     Text format     Abstract available


  156. ESCORSELL A, Garcia-Pagan JC, Bosch J
    Esophageal Stents for Acute Variceal Bleeding: Expanding the Possibilities.
    Dig Dis Sci. 2018;63:275-276.
    PubMed     Text format    


  157. MAIWALL R, Jamwal KD, Bhardwaj A, Bhadoria AS, et al
    SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure.
    Dig Dis Sci. 2018;63:493-501.
    PubMed     Text format     Abstract available


    January 2018
  158. TORRES-MENA JE, Salazar-Villegas KN, Sanchez-Rodriguez R, Lopez-Gabino B, et al
    Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Dig Dis Sci. 2018 Jan 30. pii: 10.1007/s10620-018-4943.
    PubMed     Text format     Abstract available


  159. BAFFY G
    Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-017-4903.
    PubMed     Text format     Abstract available


  160. NG PKS, Lau CPY, Lam EKY, Li SSK, et al
    Hypermethylation of NF-kappaB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4929.
    PubMed     Text format     Abstract available


  161. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    PubMed     Text format     Abstract available


  162. BURROUGHS TK, Wade JB, Ellwood MS, Fagan A, et al
    Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Dig Dis Sci. 2018 Jan 8. pii: 10.1007/s10620-017-4894.
    PubMed     Text format     Abstract available


  163. LI S, He X, Dang L, Xu F, et al
    Efficacy of (125)I Versus Non-(125)I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.
    Dig Dis Sci. 2018 Jan 5. pii: 10.1007/s10620-017-4899.
    PubMed     Text format     Abstract available


    December 2017
  164. CHOE WH, Kim JH, Park JH, Kim HU, et al
    Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2017 Dec 27. pii: 10.1007/s10620-017-4814.
    PubMed     Text format     Abstract available


  165. JONES PD, Diaz C, Wang D, Gonzalez-Diaz J, et al
    The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4869.
    PubMed     Text format     Abstract available


  166. ZHANG X, Li C, Wen T, Peng W, et al
    Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.
    Dig Dis Sci. 2017 Dec 14. pii: 10.1007/s10620-017-4861.
    PubMed     Text format     Abstract available


  167. LIN M, Chang Y, Xie F, Shi Y, et al
    ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-beta1 in Hepatic Stellate Cells by Reducing Autophagy.
    Dig Dis Sci. 2017 Dec 2. pii: 10.1007/s10620-017-4816.
    PubMed     Text format     Abstract available


  168. SUK KT, Kim MY, Jeong SW, Jang JY, et al
    Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4868.
    PubMed     Text format     Abstract available


  169. AHMAD J, Odin JA, Hayashi PH, Chalasani N, et al
    Identification and Characterization of Fenofibrate-Induced Liver Injury.
    Dig Dis Sci. 2017;62:3596-3604.
    PubMed     Text format     Abstract available


  170. YANG HJ, Chang Y, Park SK, Jung YS, et al
    Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.
    Dig Dis Sci. 2017;62:3605-3613.
    PubMed     Text format     Abstract available


  171. GLASS LM, Waljee AK, McCurdy H, Su GL, et al
    Specialty Care Access Network-Extension of Community Healthcare Outcomes Model Program for Liver Disease Improves Specialty Care Access.
    Dig Dis Sci. 2017;62:3344-3349.
    PubMed     Text format     Abstract available


    November 2017
  172. LIU H, Hu J, Pan H, Luo D, et al
    CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing beta-Catenin Ubiquitination.
    Dig Dis Sci. 2017 Nov 30. pii: 10.1007/s10620-017-4855.
    PubMed     Text format     Abstract available


  173. GANDINI R, Merolla S, Chegai F, Abrignani S, et al
    Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension.
    Dig Dis Sci. 2017 Nov 28. pii: 10.1007/s10620-017-4863.
    PubMed     Text format    


  174. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Text format     Abstract available


  175. ZHOU C, Sun Y, Guo S, Chen X, et al
    Wls Expression Correlates with Tumor Differentiation and TNM Stage in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4823.
    PubMed     Text format     Abstract available


  176. TITAN AL, Devereaux K, Louie JD, Poultsides GA, et al
    Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4797.
    PubMed     Text format    


  177. WIJARNPREECHA K, Chesdachai S, Thongprayoon C, Jaruvongvanich V, et al
    Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4834.
    PubMed     Text format     Abstract available


  178. HUANG CS, Zhai JM, Zhu XX, Cai JP, et al
    BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4829.
    PubMed     Text format     Abstract available


  179. CULLARO G, Kim G, Pereira MR, Brown RS Jr, et al
    Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4804.
    PubMed     Text format     Abstract available


  180. TANEJA S, Borkakoty A, Rathi S, Kumar V, et al
    Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease.
    Dig Dis Sci. 2017;62:3186-3192.
    PubMed     Text format     Abstract available


  181. CATRON TD, Smallfield GB, Kang L, Sterling RK, et al
    Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience.
    Dig Dis Sci. 2017;62:3091-3099.
    PubMed     Text format     Abstract available


    October 2017
  182. LU Z, Lin Y, Peng B, Bao Z, et al
    Hydrogen-Rich Saline Ameliorates Hepatic Ischemia-Reperfusion Injury Through Regulation of Endoplasmic Reticulum Stress and Apoptosis.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4811.
    PubMed     Text format     Abstract available


  183. MUDAMBI K, Berquist W
    "Blueberry Muffin" Rash and Neonatal Cholestatic Liver Failure.
    Dig Dis Sci. 2017 Oct 25. doi: 10.1007/s10620-017-4810.
    PubMed     Text format    


  184. WU W, Liu S, Liang Y, Zhou Z, et al
    Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4798.
    PubMed     Text format     Abstract available


  185. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Correction to: Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Oct 13. doi: 10.1007/s10620-017-4785.
    PubMed     Text format     Abstract available


  186. KRUGER AJ, Mumtaz K, Anaizi A, Modi RM, et al
    Cirrhosis Is Associated with Increased Mortality in Patients with Diverticulitis: A Nationwide Cross-Sectional Study.
    Dig Dis Sci. 2017 Oct 6. doi: 10.1007/s10620-017-4782.
    PubMed     Text format     Abstract available


  187. OH IS, Sinn DH, Kang TW, Lee MW, et al
    Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Dig Dis Sci. 2017 Oct 5. doi: 10.1007/s10620-017-4775.
    PubMed     Text format     Abstract available


  188. REDMAN JS, Natarajan Y, Hou JK, Wang J, et al
    Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing.
    Dig Dis Sci. 2017;62:2713-2718.
    PubMed     Text format     Abstract available


  189. KHOURY T, Asombang AW, Berzin TM, Cohen J, et al
    The Clinical Implications of Fatty Pancreas: A Concise Review.
    Dig Dis Sci. 2017;62:2658-2667.
    PubMed     Text format     Abstract available


    September 2017
  190. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    PubMed     Text format     Abstract available


  191. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    PubMed     Text format     Abstract available


  192. ROSEN E, Bakshi N, Watters A, Rosen HR, et al
    Hepatic Complications of Anorexia Nervosa.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4766.
    PubMed     Text format     Abstract available


  193. ZHANG S, Xiao J, Chai Y, Du YY, et al
    LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Dig Dis Sci. 2017 Sep 18. doi: 10.1007/s10620-017-4759.
    PubMed     Text format     Abstract available


  194. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    PubMed     Text format     Abstract available


  195. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    PubMed     Text format     Abstract available


  196. OGISO H, Ito H, Kanbe A, Ando T, et al
    The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.
    Dig Dis Sci. 2017;62:2386-2396.
    PubMed     Text format     Abstract available


  197. LUTZ P, Goeser F, Kaczmarek DJ, Schlabe S, et al
    Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2017;62:2558-2568.
    PubMed     Text format     Abstract available


  198. DE LEDINGHEN V, Hiriart JB, Vergniol J, Merrouche W, et al
    Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan((R)): A Comparative Study with the M Probe and Liver Biopsy.
    Dig Dis Sci. 2017;62:2569-2577.
    PubMed     Text format     Abstract available


    August 2017
  199. CHEDID MF
    Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.
    Dig Dis Sci. 2017 Aug 24. doi: 10.1007/s10620-017-4724.
    PubMed     Text format    


  200. CHENG L, Wang H, Han S
    MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 19. doi: 10.1007/s10620-017-4670.
    PubMed     Text format     Abstract available


  201. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4708.
    PubMed     Text format     Abstract available


  202. XU H, Xiong J, Xu J, Li S, et al
    Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4704.
    PubMed     Text format     Abstract available


  203. GREMIDA A, Al-Taee A, Alcorn J, McCarthy D, et al
    Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?
    Dig Dis Sci. 2017 Aug 7. doi: 10.1007/s10620-017-4706.
    PubMed     Text format    


  204. LEE HW, Kim BK, Kim SU, Park JY, et al
    Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2017;62:2150-2158.
    PubMed     Text format     Abstract available


  205. JIMENEZ JV, Carrillo-Perez DL, Rosado-Canto R, Garcia-Juarez I, et al
    Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.
    Dig Dis Sci. 2017;62:1855-1871.
    PubMed     Text format     Abstract available


    July 2017
  206. CHOLANKERIL G, Wong RJ, Hu M, Perumpail RB, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4684.
    PubMed     Text format     Abstract available


  207. EUN HS, Lee BS, Kwon IS, Yun GY, et al
    Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4688.
    PubMed     Text format     Abstract available


  208. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    PubMed     Text format    


    June 2017
  209. YANG C, Gomez A, Haldipur A, Berquist W, et al
    Growing Concerns: A 3-Year-Old Girl with Multiple Hepatic Masses and Gastrointestinal Bleeding.
    Dig Dis Sci. 2017 Jun 23. doi: 10.1007/s10620-017-4644.
    PubMed     Text format    


  210. FITTIPALDI S, Vasuri F, Bonora S, Degiovanni A, et al
    miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4654.
    PubMed     Text format     Abstract available


  211. WU S, Yang C, Xu N, Wang L, et al
    The Protective Effects of Helix B Surface Peptide on Experimental Acute Liver Injury Induced by Carbon Tetrachloride.
    Dig Dis Sci. 2017;62:1537-1549.
    PubMed     Text format     Abstract available


  212. SAFADI S, Mohamed AM, Altamimi BA, Strickland RG, et al
    Decompensated Liver Disease in a Patient with Neurocysticercosis.
    Dig Dis Sci. 2017;62:1443-1447.
    PubMed     Text format    


    May 2017
  213. PANTHAM G, Post A, Venkat D, Einstadter D, et al
    A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Dig Dis Sci. 2017 May 30. doi: 10.1007/s10620-017-4630.
    PubMed     Text format     Abstract available


  214. WALLACE MC, Huang Y, Preen DB, Garas G, et al
    HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4622.
    PubMed     Text format     Abstract available


  215. DE MATTEIS S, Granato AM, Napolitano R, Molinari C, et al
    Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 19. doi: 10.1007/s10620-017-4615.
    PubMed     Text format     Abstract available


  216. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    PubMed     Text format     Abstract available


  217. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Text format     Abstract available


  218. DOYCHEVA I, Watt KD, Rifai G, Abou Mrad R, et al
    Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
    Dig Dis Sci. 2017;62:1373-1380.
    PubMed     Text format     Abstract available


  219. GAIDOS JKJ, Fuchs M
    Increased Prevalence of NAFLD in IBD Patients.
    Dig Dis Sci. 2017;62:1362.
    PubMed     Text format    


    April 2017
  220. HAMARNEH SR, Kim BM, Kaliannan K, Morrison SA, et al
    Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice.
    Dig Dis Sci. 2017 Apr 19. doi: 10.1007/s10620-017-4576.
    PubMed     Text format     Abstract available


  221. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    PubMed     Text format     Abstract available


  222. TESCHKE R, Eickhoff A
    Suspected Liver Injury and the Dilemma of Causality.
    Dig Dis Sci. 2017;62:1095-1098.
    PubMed     Text format     Abstract available


    March 2017
  223. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Text format     Abstract available


  224. KOHLI DR, Vachhani R, Shah TU, BouHaidar DS, et al
    Diagnostic Accuracy of Laboratory Tests and Diagnostic Imaging in Detecting Biliary Strictures After Liver Transplantation.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4515.
    PubMed     Text format     Abstract available


  225. O'LEARY JG, Wong F, Reddy KR, Garcia-Tsao G, et al
    Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.
    Dig Dis Sci. 2017;62:768-776.
    PubMed     Text format     Abstract available


  226. HEIDEMANN L, Law J, Fontana RJ
    A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.
    Dig Dis Sci. 2017;62:615-625.
    PubMed     Text format     Abstract available


    February 2017
  227. LIN MX, Ye JY, Tian WS, Xu M, et al
    Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.
    Dig Dis Sci. 2017 Feb 15. doi: 10.1007/s10620-016-4312.
    PubMed     Text format     Abstract available


  228. BALAKRISHNAN M, El-Serag HB, Kanwal F, Thrift AP, et al
    Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
    Dig Dis Sci. 2017;62:526-533.
    PubMed     Text format     Abstract available


  229. KUO SZ, Haftek M, Lai JC
    Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2017;62:543-549.
    PubMed     Text format     Abstract available


    January 2017
  230. ZHAO D, Luo Y, Xia Y, Zhang JJ, et al
    MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.
    Dig Dis Sci. 2017 Jan 12. doi: 10.1007/s10620-016-4411.
    PubMed     Text format     Abstract available


  231. LEIBOVICI-WEISSMAN Y, Mor E, Leshno M, Shlomai A, et al
    Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.
    Dig Dis Sci. 2017 Jan 4. doi: 10.1007/s10620-016-4423.
    PubMed     Text format     Abstract available


  232. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Text format     Abstract available


    November 2016
  233. DONOVAN RJ, Choi C, Ali A, Heuman DM, et al
    Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    October 2016
  234. HA TH, Kim BG, Jeong D, Oh S, et al
    Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    August 2016
  235. SOTIROPOULOS GC, Vernadakis S, Paul A, Hoyer DP, et al
    Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  236. HEGADE VS, Khanna A, Walker LJ, Wong LL, et al
    Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    March 2016
  237. JARUVONGVANICH V, Sanguankeo A, Upala S
    Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: